Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 protease.
Bioorg Med Chem Lett
; 20(24): 7493-7, 2010 Dec 15.
Article
em En
| MEDLINE
| ID: mdl-21041080
ABSTRACT
HCV NS3/4A serine protease is essential for the replication of the HCV virus and has been a clinically validated target. A series of HCV NS3/4A protease inhibitors containing a novel acylsulfamoyl benzoxaborole moiety at the P1' region was synthesized and evaluated. The resulting P1-P3 and P2-P4 macrocyclic inhibitors exhibited sub-nanomolar potency in the enzymatic assay and low nanomolar activity in the cell-based replicon assay. The in vivo PK evaluations of selected compounds are also described.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Inibidores de Proteases
/
Compostos de Boro
/
Proteínas não Estruturais Virais
/
Hepacivirus
Idioma:
En
Ano de publicação:
2010
Tipo de documento:
Article